Nathaniel

T. Hopkins

Associate
Dallas
500 N. Akard Street, Suite 4000
Dallas, TX 75201-6605
D.214.740.5167
E.nhopkins@munsch.com

Overview

Nathan’s practice focuses on mergers and acquisitions and a broad range of corporate matters for clients in industries such as health care, energy, manufacturing, real estate and technology. He regularly drafts and negotiates agreements, conducts due diligence and manages closing activities for middle-market M&A transactions. He also advises clients in business formation, restructuring, corporate governance and securities matters.

Prior to joining Munsch Hardt, Nathan served as an associate at a national law firm in its Houston office.

 

Education

  • Southern Methodist University, Dedman School of Law, J.D., cum laude
    • SMU Law Review Journal (Casenote and Comment Editor)
  • George Washington University, B.A.

Admission

  • Texas

Achievements

  • Woodward/White, Inc. – Best Lawyers: Ones to Watch, Corporate Law (2024-2025)

  • Memberships

    Houston Young Lawyers Association (HYLA)

Overview

Nathan’s practice focuses on mergers and acquisitions and a broad range of corporate matters for clients in industries such as health care, energy, manufacturing, real estate and technology. He regularly drafts and negotiates agreements, conducts due diligence and manages closing activities for middle-market M&A transactions. He also advises clients in business formation, restructuring, corporate governance and securities matters.

Prior to joining Munsch Hardt, Nathan served as an associate at a national law firm in its Houston office.

 

Experience

  • Management Company Disposition

    Represented an IT strategy and consulting firm, specializing in enterprise cloud and data analytics advisory services, in the sale to a publicly traded company.

  • HVAC Supplier Disposition

    Represented an HVAC and refrigeration wholesale supplier in its sale to a competitor. The deal was valued at more than $60 MM.

  • Background Check Company Disposition

    Represented an employee screening solutions provider, primarily focused on drug testing and background screening, in its sale to a private equity-backed competitor.

[more]

Newsroom